I trained in neurology in the East of England (Cambridge, Norwich and London).
During this time, I completed my PhD in the neuro-immunology of multiple sclerosis (2006-2010) with Professor Alasdair Coles at the University of Cambridge. I was an investigator on the phase II and phase III trials of alemtuzumab in relapsing-remitting MS. I also studied the response to vaccination of MS patients treated with alemtuzumab through a phase IV clinical trial.